journal article·2024-01-17Open access

Exploring the Impact of Nanoparticle Stealth Coatings in Cancer Models: From PEGylation to Cell Membrane-Coating Nanotechnology

Pablo Graván, Jesús Peña-Martín, Julia López de Andrés, María Pedrosa, Martín Villegas-Montoya, Francisco Galisteo-González, Juan A. Marchal, Paola Sánchez-Moreno

Abstract

Nanotechnological platforms offer advantages over conventional therapeutic and diagnostic modalities. However, the efficient biointerfacing of nanomaterials for biomedical applications remains challenging. In recent years, nanoparticles (NPs) with different coatings have been developed to reduce nonspecific interactions, prolong circulation time, and improve therapeutic outcomes. This study aims to compare various NP coatings to enhance surface engineering for more effective nanomedicines. We prepared and characterized polystyrene NPs with different coatings of poly(ethylene glycol), bovine serum albumin, chitosan, and cell membranes from a human breast cancer cell line. The coating was found to affect the colloidal stability, adhesion, and elastic modulus of NPs. Protein corona formation and cellular uptake of NPs were also investigated, and a 3D tumor model was employed to provide a more realistic representation of the tumor microenvironment. The prepared NPs were found to reduce protein adsorption, and cell-membrane-coated NPs showed significantly higher cellular uptake. The secretion of proinflammatory cytokines in human monocytes after incubation with the prepared NPs was evaluated. Overall, the study demonstrates the importance of coatings in affecting the behavior and interaction of nanosystems with biological entities. The findings provide insight into bionano interactions and are important for the effective implementation of stealth surface engineering designs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Applied Physics, Faculty of Science, University of Granada, 18071 Granada, Spain

Department of Human Anatomy and Embryology, Faculty of Medicine, University of Granada, 18016 Granada, Spain

Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), 18012 Granada, Spain

Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM), University of Granada, 18016 Granada, Spain

Excellence Research Unit Modelling Nature (MNat), University of Granada, 18016 Granada, Spain

BioFab i3D─Biofabrication and 3D (bio)printing laboratory, University of Granada, 18100 Granada, Spain

Faculty of Biology, Calzada de las Américas and University, Ciudad Universitaria, 80040 Culiacán, Sinaloa, Mexico

Funding

Ministerio de Ciencia e Innovaci?n · Universidad de Granada

References (67)

Show source-provided references
1. 10.1021/acsnano.6b0604010.1021/acsnano.6b06040 ↗
2. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
3. 10.1002/BTM2.1000310.1002/BTM2.10003 ↗
4. 10.1038/natrevmats.2016.1410.1038/natrevmats.2016.14 ↗
5. 10.1016/j.taap.2016.01.00510.1016/j.taap.2016.01.005 ↗
6. 10.1038/nbt.333010.1038/nbt.3330 ↗
7. 10.1021/la500057j10.1021/la500057j ↗
8. 10.1002/wnan.133910.1002/wnan.1339 ↗
9. 10.2174/092986732566618060110185910.2174/0929867325666180601101859 ↗
10. 10.1039/C8BM00692J10.1039/C8BM00692J ↗
11. 10.3109/10717544.2015.104848810.3109/10717544.2015.1048488 ↗
12. 10.1016/j.reactfunctpolym.2019.10445910.1016/j.reactfunctpolym.2019.104459 ↗
13. 10.1021/nl500618u10.1021/nl500618u ↗
14. 10.1002/adma.20170675910.1002/adma.201706759 ↗
15. 10.3390/cancers1401019010.3390/cancers14010190 ↗
16. 10.1088/1758-5090/ac48e410.1088/1758-5090/ac48e4 ↗
17. 10.1016/j.actbio.2020.02.00610.1016/j.actbio.2020.02.006 ↗
18. 10.3390/pharmaceutics1307106910.3390/pharmaceutics13071069 ↗
19. 10.1016/j.biomaterials.2018.01.00710.1016/j.biomaterials.2018.01.007 ↗
20. 10.1038/s41565-018-0254-410.1038/s41565-018-0254-4 ↗
21. 10.1038/s41467-021-26052-x10.1038/s41467-021-26052-x ↗
22. 10.1038/srep3442210.1038/srep34422 ↗
23. 10.1038/s41598-021-03422-510.1038/s41598-021-03422-5 ↗
24. 10.1021/bm401103t10.1021/bm401103t ↗
25. Frank L. A. · React. Funct. Polym. · 2020 · 147 · 10445910.1016/j.reactfunctpolym.2019.104459 ↗
26. 10.1002/ADMA.20200180810.1002/ADMA.202001808 ↗
27. 10.1021/jp912035v10.1021/jp912035v ↗
28. Baleux B. · C. R. Acad. Sci. Hebd. Seances Acad. Sci. · 1972 · 274 · 1617
29. 10.1080/0149639090288121210.1080/01496390902881212 ↗
30. 10.3389/fbioe.2020.0057310.3389/fbioe.2020.00573 ↗
31. 10.1016/0003-2697(71)90132-110.1016/0003-2697(71)90132-1 ↗
32. 10.1021/nn203851610.1021/nn2038516 ↗
33. 10.1021/j150453a00110.1021/j150453a001 ↗
34. 10.3390/IJMS1302240510.3390/IJMS13022405 ↗
35. 10.1021/la981445s10.1021/la981445s ↗
36. 10.1039/C4CS00487F10.1039/C4CS00487F ↗
37. 10.3390/ma1223383310.3390/ma12233833 ↗
38. 10.1021/acsnano.9b0392410.1021/acsnano.9b03924 ↗
39. 10.1021/nn301159a10.1021/nn301159a ↗
40. 10.1039/C7CP08644J10.1039/C7CP08644J ↗
41. 10.1098/rsos.16024810.1098/rsos.160248 ↗
42. 10.1039/C9RA09523C10.1039/C9RA09523C ↗
43. 10.1016/j.drudis.2021.04.01410.1016/j.drudis.2021.04.014 ↗
44. 10.1021/ja208433810.1021/ja2084338 ↗
45. 10.1016/j.biomaterials.2013.07.10210.1016/j.biomaterials.2013.07.102 ↗
46. 10.1021/acsami.6b1445010.1021/acsami.6b14450 ↗
47. 10.1021/acsbiomaterials.1c0080410.1021/acsbiomaterials.1c00804 ↗
48. 10.1016/j.biomaterials.2015.04.04910.1016/j.biomaterials.2015.04.049 ↗
49. 10.1016/j.msec.2016.09.01610.1016/j.msec.2016.09.016 ↗
50. 10.3390/nano1011223610.3390/nano10112236 ↗
51. 10.1021/acs.bioconjchem.9b0013610.1021/acs.bioconjchem.9b00136 ↗
52. 10.1101/2021.03.18.43602410.1101/2021.03.18.436024 ↗
53. 10.1016/j.trsl.2021.11.00810.1016/j.trsl.2021.11.008 ↗
54. 10.1016/S0142-9612(03)00595-710.1016/S0142-9612(03)00595-7 ↗
55. 10.1097/TP.000000000000145210.1097/TP.0000000000001452 ↗
56. 10.1016/S1470-2045(03)01196-310.1016/S1470-2045(03)01196-3 ↗
57. Ohls, R. K. Hematology, Immunology and Infectious Disease: Neonatology Questions and Controversies; Elsevier Health Sciences, 2012; pp 1–345.
58. 10.1073/pnas.90.8.353910.1073/pnas.90.8.3539 ↗
59. 10.1016/S0923-1811(96)00589-010.1016/S0923-1811(96)00589-0 ↗
60. 10.1002/ADMA.20170396910.1002/ADMA.201703969 ↗
61. 10.3390/membranes1208073810.3390/membranes12080738 ↗
62. 10.1021/acsnano.8b0529210.1021/acsnano.8b05292 ↗
63. 10.1007/bf0197279410.1007/bf01972794 ↗
64. 10.1007/s10072-009-0123-x10.1007/s10072-009-0123-x ↗
65. 10.1038/srep1842310.1038/srep18423 ↗
66. 10.1016/j.toxlet.2015.10.01810.1016/j.toxlet.2015.10.018 ↗
67. 10.1007/s10565-013-9265-y10.1007/s10565-013-9265-y ↗